Clinical Trials Browser

OTHER × Vinorelbine × Thoracic × Clear all

NCT06632327 2026-03-04

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Phase 3 Recruiting

Lung Neoplasms

NCT04648033 2026-01-29

ARCADIAN

Phase 1 Completed

21 enrolled 21 charts

Locally Advanced Non-Small Cell Lung Cancer

NCT06576635 2026-01-20

LUNG-05

Phase NA Recruiting

NSCLC

NCT06908993 2025-12-17

COMET

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04765709 2025-12-16

BRIDGE

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT07001618 2025-07-23

IMMUNOLIFE2

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00540982 2025-07-02

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

Phase 1/2 Completed

47 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00309998 2024-10-29

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Phase 2 Unknown

Advanced Non-Small Cell Lung Cancer

NCT02974426 2024-06-12

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02709720 2024-01-11

NORA

Phase 2 Completed

68 enrolled 21 charts

Lung Neoplasms

NCT00602797 2023-09-26

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT03345810 2023-06-15

DURATION

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02555007 2022-11-17

NVB Metro

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT05603013 2022-11-02

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Phase 2 Unknown

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00887783 2022-05-17

NARLAL

Phase 2 Completed

117 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT03801304 2022-05-12

VinMetAtezo

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02139904 2021-10-12

VIM

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma

NCT02644252 2021-05-03

Toco-Pulm

Phase 3 Terminated

Lung Neoplasms

NCT02977169 2020-11-13

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Carcinoma, Non-Small-Cell Lung

NCT02985203 2020-03-12

Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer

Phase 2 Terminated

Lung Neoplasms

NCT03652857 2020-02-17

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

Phase 2 Completed

Advanced Non Small Cell Lung Cancer

NCT04208854 2019-12-26

VINORELBINA

Locally Advanced/ Metastatic NSCLC

NCT02603003 2019-09-20

CTC-TCM-FZ

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT01848613 2018-11-09

VIVOS

Phase 4 Completed

Non-small Cell Lung Cancer Metastatic

NCT03656393 2018-09-04

RCTACSCNSCLC

Phase 3 Unknown

NSCLC

NCT01443078 2018-08-09

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Phase 2 Completed

42 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Phase 1/2 Terminated

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00287963 2018-05-17

Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer

Phase 1 Completed

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT01029678 2018-05-03

RACCOSA

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02919462 2018-01-16

HighTySy

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00215930 2017-03-23

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

53 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT02795884 2016-12-30

Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation

Phase 3 Withdrawn

Lung Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01683175 2016-10-20

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00755170 2016-10-04

Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00008333 2016-07-13

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01155258 2016-06-13

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

BreastCNSDermatologicEndocrineGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

NCT00198432 2016-03-10

Chemoradiotherapy of NSCLC Stage IIIB

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT01684111 2016-01-18

VENUS-1

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT00345059 2016-01-14

DISTAL-2

Phase 3 Terminated

Advanced Non-Small Cell Lung Cancer

NCT00401609 2016-01-14

G-Step

Phase 1/2 Completed

Small Cell Lung Carcinoma

NCT00675597 2015-11-20

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Phase NA Completed

25 enrolled 6 charts

Lung Neoplasms

NCT00391586 2015-08-17

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

Phase 2 Terminated

45 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Phase NA Completed

6 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

NCT01683682 2015-01-26

VENUS-2

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT02319577 2014-12-18

GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung